EN DE
STOCK COMPARISON

PT Diastika Biotekindo Tbk vs Abbott Laboratories: Fair Value & Quality

Both stocks run through our valuation models. Here is how PT Diastika Biotekindo Tbk (CHEK) and Abbott Laboratories (ABT) compare, as of Aug 11, 2026.

As of Aug 11, 2026, Fair Value Calculator sees Abbott Laboratories as the less overvalued of the two: PT Diastika Biotekindo Tbk trades at IDR 134 versus a fair value of IDR 68 (-49%), while Abbott Laboratories trades at $108 versus $74.79 (-31%).
PT Diastika Biotekindo Tbk
CHEK.JK · IDR · Healthcare
-49%
upside to fair value
overvalued
PriceIDR 134
Fair ValueIDR 68
Quality42/100
Abbott Laboratories
ABT · USD · Health Care
-31%
upside to fair value
overvalued
Price$108
Fair Value$74.79
Quality67/100

Head-to-head numbers

Green value = the better side for that row (for valuation multiples: lower = cheaper).

PT Diastika Biotekindo TbkAbbott Laboratories
Valuation
—P/E (TTM)27.7×
—P/S (TTM)3.89×
—P/B3.36×
—EV/EBITDA15.1×
—PEG1.47×
Profitability
6%Net margin14%
3%Operating margin13%
8%Return on equity12%
6%Return on assets6%
Growth
5%Revenue growth (YoY)8%
—Avg. growth/yr (3Y)0.5%
—Avg. growth/yr (5Y)5.1%
Balance & size
—Debt / equity0.19×
$55MMarket cap$175B
expensiveGrowth qualityhealthy

Abbott Laboratories leads: 1 to 4 metric wins.

Dash = not meaningfully computable, for example with negative equity.

Quality in detail

The quality score, broken down into the same factor families as on the stock page, 0 to 100 per family.

PT Diastika Biotekindo Tbkof which business quality 44 · market factors 31 Abbott Laboratoriesof which business quality 66 · market factors 51
ProfitabilityMargins and returns on capital today
45
50
Quality GrowthAre margins and returns improving?
35
47
CashflowEarnings quality: real cash, not paper profit
0
71
Fin. StrengthBalance sheet, leverage, solvency risk
85
80
InvestmentDisciplined investing over empire-building
33
65
Low VolatilityCalm price path (market factor)
53
83
MomentumPrice trend over the last 3–12 months (market factor)
28
40
52W MomentumDistance to the 52-week high (market factor)
9
33
Net IssuanceBuybacks instead of dilution
68
84

What the models say

The median fair value (base case) per model family, each in the currency of its trading venue. Green = above the current price, red = below.

PT Diastika Biotekindo Tbk

Earnings-BasedIDR 95
Dividend DiscountIDR 15
MultiplesIDR 68
Asset-BasedIDR 34
Economic ProfitIDR 55
Growth EarningsIDR 116

14 of 15 models see the stock below the current price.

Abbott Laboratories

DCF Models$73.01
Earnings-Based$29.42
Dividend Discount$39.73
Multiples$70.72
Asset-Based$20.05
Growth DCF$67.02
Economic Profit$37.49
Growth Earnings$70.25

26 of 26 models see the stock below the current price.

Scenario ranges

From our cautious bear case to the optimistic bull case. The white tick is the current price: left of fair value means room to run.

PT Diastika Biotekindo Tbk
Bear IDR 51Fair Value IDR 68Bull IDR 85
IDR 134 = current price (white tick)
Abbott Laboratories
Bear $51.84Fair Value $74.79Bull $94.43
$108 = current price (white tick)

Compare two other stocks

Tap a field and type again, ticker or company name.

Free, no sign-up

Ranked within their sector

Where each stock sits within its sector peer group. Band = middle 50% of peers, tick = median, dot = this stock.

PT Diastika Biotekindo Tbk · Healthcare

Quality score42 · below median
Fair value upside-49% · below median

Abbott Laboratories · Health Care

Quality score67 · Top 25%
Fair value upside-31% · below median

Bottom line

As of Aug 11, 2026, Fair Value Calculator sees Abbott Laboratories as the less overvalued of the two: PT Diastika Biotekindo Tbk trades at IDR 134 versus a fair value of IDR 68 (-49%), while Abbott Laboratories trades at $108 versus $74.79 (-31%).

Abbott Laboratories has the higher quality score (67/100).

See the full analysis →
PT Diastika Biotekindo Tbk · Abbott Laboratories

More comparisons

Popular match-ups from the same sectors, all with fair value and quality score.

Related to PT Diastika Biotekindo Tbk

Alphabet Inc Class C vs Verizon CommunicationsAlphabet Inc Class C vs At&tAlphabet Inc Class C vs NetEaseAmazon.com vs Toyota Motor Corporation

Related to Abbott Laboratories

UnitedHealth Group vs Abbott LaboratoriesEli Lilly and vs UnitedHealth GroupJohnson & Johnson vs UnitedHealth GroupAbbVie vs UnitedHealth Group
Free · Top-25 report

See the undervalued quality stocks every month

Just your email for the monthly Top-25 report of the most undervalued quality stocks, with fair value, quality and price target. Plus 14 days of Pro to try, no card.

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click. Not financial advice.

A model-based valuation snapshot from 21 models. Values change with price and fundamentals; the date shown above applies.